Anixa Biosciences Inc (ANIX)
3.57
+0.10
(+2.88%)
USD |
NASDAQ |
Nov 05, 16:00
3.57
0.00 (0.00%)
After-Hours: 18:21
Anixa Biosciences Max Drawdown (5Y): 80.00% for Oct. 31, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| October 31, 2024 | 80.00% |
| September 30, 2024 | 80.00% |
| August 31, 2024 | 80.00% |
| July 31, 2024 | 80.00% |
| June 30, 2024 | 80.00% |
| May 31, 2024 | 80.00% |
| April 30, 2024 | 80.00% |
| March 31, 2024 | 80.00% |
| February 29, 2024 | 80.00% |
| January 31, 2024 | 80.00% |
| December 31, 2023 | 80.00% |
| November 30, 2023 | 80.00% |
| October 31, 2023 | 80.00% |
| September 30, 2023 | 80.00% |
| August 31, 2023 | 80.00% |
| July 31, 2023 | 80.00% |
| June 30, 2023 | 80.00% |
| May 31, 2023 | 80.00% |
| April 30, 2023 | 80.00% |
| March 31, 2023 | 80.00% |
| February 28, 2023 | 80.00% |
| January 31, 2023 | 80.00% |
| December 31, 2022 | 80.00% |
| November 30, 2022 | 80.00% |
| October 31, 2022 | 80.00% |
| Date | Value |
|---|---|
| September 30, 2022 | 80.00% |
| August 31, 2022 | 80.00% |
| July 31, 2022 | 81.54% |
| June 30, 2022 | 93.65% |
| May 31, 2022 | 94.23% |
| April 30, 2022 | 94.23% |
| March 31, 2022 | 94.23% |
| February 28, 2022 | 94.23% |
| January 31, 2022 | 94.23% |
| December 31, 2021 | 94.23% |
| November 30, 2021 | 94.23% |
| October 31, 2021 | 94.23% |
| September 30, 2021 | 94.23% |
| August 31, 2021 | 94.23% |
| July 31, 2021 | 94.23% |
| June 30, 2021 | 94.23% |
| May 31, 2021 | 94.23% |
| April 30, 2021 | 94.23% |
| March 31, 2021 | 94.23% |
| February 28, 2021 | 94.23% |
| January 31, 2021 | 94.23% |
| December 31, 2020 | 94.23% |
| November 30, 2020 | 94.23% |
| October 31, 2020 | 94.23% |
| September 30, 2020 | 94.23% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
80.00%
Minimum
Aug 2022
94.23%
Maximum
Nov 2019
87.61%
Average
94.23%
Median
Nov 2019
Max Drawdown (5Y) Benchmarks
| Annovis Bio Inc | -- |
| Akero Therapeutics Inc | 79.99% |
| ACADIA Pharmaceuticals Inc | 77.18% |
| Amicus Therapeutics Inc | 74.97% |
| Intra-Cellular Therapies Inc | 79.05% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -15.23 |
| Beta (5Y) | 0.8424 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 67.95% |
| Historical Sharpe Ratio (5Y) | -0.0641 |
| Historical Sortino (5Y) | -0.1182 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 28.04% |